4148
全宇生技-KY
0.14%
(0.00)
全宇生技-KY (4148.TW) 2025Q4 financial report shows revenue of 831.76M TWD, with a YoY growth rate of 17.08%. This data clearly demonstrates significant revenue growth, with the company showing strong operational momentum and a marked increase in market demand. To fully capture future growth potential and investment opportunities, investors should closely monitor 全宇生技-KY (4148.TW)’s upcoming financial reports and key strategic adjustments, and leverage diversified data analysis, especially advanced tools like Growin AI Value Analysis, for a comprehensive and forward-looking evaluation.